Worldwide Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2019 to 2023) - Forecast and Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The cardiac monitoring & cardiac rhythm management devices market analysis considers sales from both cardiac rhythm management devices and cardiac monitoring devices in Asia, Europe, North America, and ROW. In 2018, the cardiac rhythm management devices segment had a significant market share, and this trend is expected to continue over the forecast period.

Factors such as rising product launches and the growing focus on R&D for the development of advanced devices will play a significant role in the cardiac rhythm management devices segment to maintain its market position. Also, our global cardiac monitoring & cardiac rhythm management devices market report looks at factors such as increasing prevalence of CVDs, increasing awareness initiatives and access to healthcare, and technological advances and new product launches. However, high costs of CM and CRM devices, shortage of skilled clinicians, and increasing enforcement of stringent regulations may hamper the growth of the cardiac monitoring & cardiac rhythm management devices industry over the forecast period.

Increasing awareness initiatives and access to healthcare

Public and private organizations are taking initiatives to promote awareness about CVDs and lung diseases. For instance, The Sudden Cardiac Arrest (SCA) Foundation is focusing on increasing awareness and influence attitudinal and behavioral changes for reducing mortality and morbidity from SCA. The Asia Pacific Heart Rhythm Society (APHRS) is another organization focusing on advancing the diagnosis and treatment of patients with heart rhythm disorders in APAC. Such initiatives by organizations lead to an increase in the diagnosis and treatment of CVDs leading to the expansion of the global cardiac monitoring & cardiac rhythm management devices market at a CAGR of almost 5% during the forecast period.

Increasing use of cardiac implants

Cardiac implants like pacemakers, ICDs, and CRT devices, are significantly increasing in several developing and developed countries. The significant improvements in the technology of cardiac implants and patient outcomes have improved experience and confidence of cardiac surgeons to operate on high-risk. Factors driving the utilization of cardiac implants are rising replacement rate of CRM devices; the increasing number of CRM devices implantation facilities; and the growing prevalence of CVDs. This development is expected to have a positive impact on the overall market growth.

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. SCOPE OF THE REPORT

• Preface
• Currency conversion rates for US$

3. MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

4. MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

5. FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

6. MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Cardiac rhythm management devices - Market size and forecast 2018-2023
• Cardiac monitoring devices - Market size and forecast 2018-2023
• Market opportunity by product

7. CUSTOMER LANDSCAPE

8. GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

9. DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

10. MARKET TRENDS

• Increasing number of acquisition and strategic collaborations
• Increasing R&D focus
• Increasing utilization of cardiac implants

11. VENDOR LANDSCAPE

• Overview
• Landscape disruption

12. VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors

13. APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

Companies Mentioned

• Abbott Laboratories
• Abiomed Inc.
• Asahi Kasei Corp.
• Biotronik Inc.
• Boston Scientific Corp.
• General Electric Co.
• Hill-Rom Holdings Inc.
• Koninklijke Philips NV
• Medtronic Plc
• SCHILLER AG.
  

For more information about this report visit https://www.researchandmarkets.com/r/gh8u4l